IPF-Acute Exacerbations: Advances and Future Perspectives.
作者信息
Papiris Spyros A, Kolilekas Lykourgos, Kagouridis Konstantinos, Maniati Maria, Manali Effrosyni D
机构信息
2ndPulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
7th Pulmonary Department, Athens Chest Hospital "Sotiria", Athens, Greece.
出版信息
Front Pharmacol. 2022 Apr 14;13:836553. doi: 10.3389/fphar.2022.836553. eCollection 2022.
Abstract
摘要
相似文献
1
IPF-Acute Exacerbations: Advances and Future Perspectives.特发性肺纤维化急性加重：进展与未来展望。
Front Pharmacol. 2022 Apr 14;13:836553. doi: 10.3389/fphar.2022.836553. eCollection 2022.
2
Serum torque teno virus DNA titer in idiopathic pulmonary fibrosis patients with acute respiratory worsening.急性呼吸状况恶化的特发性肺纤维化患者的血清细小病毒B19 DNA滴度
Intern Med. 2015;54(9):1015-9. doi: 10.2169/internalmedicine.54.3610. Epub 2015 May 1.
3
Idiopathic pulmonary fibrosis acute exacerbations: where are we now?特发性肺纤维化急性加重：我们目前处于什么阶段？
Expert Rev Respir Med. 2014 Jun;8(3):271-3. doi: 10.1586/17476348.2014.896206. Epub 2014 Mar 22.
4
Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?特发性肺纤维化急性加重：急性呼吸窘迫综合征的经验教训？
Crit Care. 2018 Mar 23;22(1):80. doi: 10.1186/s13054-018-2002-4.
5
The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells.NLRP3 炎性小体-半胱天冬酶-1 通路在特发性肺纤维化和急性加重期上调，并可被凋亡的 A549 细胞诱导。
Front Immunol. 2021 Apr 23;12:642855. doi: 10.3389/fimmu.2021.642855. eCollection 2021.
6
Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.临床综述：特发性肺纤维化急性加重——揭开阿里阿德涅之线。
Crit Care. 2010;14(6):246. doi: 10.1186/cc9241. Epub 2010 Dec 22.
7
Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: a retrospective study.支气管肺泡灌洗在特发性肺纤维化急性加重期诊断中的作用：一项回顾性研究
BMC Pulm Med. 2015 Jul 10;15:70. doi: 10.1186/s12890-015-0066-3.
8
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.特发性肺纤维化急性加重症（AE-IPF）：当前和未来治疗策略概述。
Expert Rev Respir Med. 2020 Apr;14(4):405-414. doi: 10.1080/17476348.2020.1724096. Epub 2020 Feb 3.
9
Acute exacerbations of idiopathic pulmonary fibrosis.特发性肺纤维化的急性加重
Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43. doi: 10.1164/rccm.200703-463PP. Epub 2007 Jun 21.
10
Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Toll样受体3 L412F多态性与特发性肺纤维化急性加重期感染的潜在关联
Am J Respir Crit Care Med. 2022 Mar 1;205(5):550-562. doi: 10.1164/rccm.202010-3880OC.
本文引用的文献
1
Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.全球专业和非专业间质性肺疾病中心特发性肺纤维化急性加重的管理
Front Med (Lausanne). 2021 Sep 27;8:699644. doi: 10.3389/fmed.2021.699644. eCollection 2021.
2
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.环磷酰胺联合糖皮质激素治疗特发性肺纤维化急性加重（EXAFIP）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7.
3
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.抗微生物治疗对特发性肺纤维化成人患者呼吸住院或死亡的影响：CleanUP-IPF 随机临床试验。
JAMA. 2021 May 11;325(18):1841-1851. doi: 10.1001/jama.2021.4956.
4
Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.皮质类固醇治疗急诊就诊的间质性肺疾病急性加重患者的反应性。
Sci Rep. 2021 Mar 11;11(1):5762. doi: 10.1038/s41598-021-85539-1.
5
Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.特发性肺纤维化终末期肺部微生物组的地形异质性：肺器官培养物中的微生物组-2 研究（MiLEs-2）。
Thorax. 2021 Mar;76(3):239-247. doi: 10.1136/thoraxjnl-2020-214770. Epub 2020 Dec 2.
6
Is corticosteroid use truly not associated with improved outcomes in AE-IPF?在特发性肺纤维化急性加重期（AE-IPF）中，使用皮质类固醇激素真的与改善预后无关吗？
Respirology. 2020 Jun;25(6):659. doi: 10.1111/resp.13826. Epub 2020 Apr 19.
7
Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay.耶氏肺孢子菌定植及其与肺部疾病的关系：基于改良环介导等温扩增检测法的多中心研究。
BMC Pulm Med. 2020 Mar 20;20(1):70. doi: 10.1186/s12890-020-1111-4.
8
Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.皮质类固醇的使用与 IPF 急性加重期的改善结果无关。
Respirology. 2020 Jun;25(6):629-635. doi: 10.1111/resp.13753. Epub 2019 Dec 17.
9
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.肺部微生物组促进肺纤维化中的肺部炎症和疾病进展。
Am J Respir Crit Care Med. 2019 May 1;199(9):1127-1138. doi: 10.1164/rccm.201809-1650OC.
10
The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.感染在特发性肺纤维化急性加重中的作用。
Mediators Inflamm. 2019 Jan 3;2019:5160694. doi: 10.1155/2019/5160694. eCollection 2019.
Zotero 插件